CLINICAL TRIALS PROFILE FOR LEVONORGESTREL
✉ Email this page to a colleague
All Clinical Trials for LEVONORGESTREL
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00064766 ↗ | Norplant and Irregular Bleeding/Spotting | Unknown status | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Phase 4 | 2003-02-01 | Irregular or prolonged menstrual bleeding and/or spotting are common side effects in patients using progestin-only hormonal contraception such as levonorgestrel implants (Norplant). Doxycycline, a drug approved by the Food and Drug Administration (FDA) to treat gum disease, may reduce the occurrence of uterine bleeding and spotting in women who use Norplant. This study will evaluate the effects of doxycycline on uterine bleeding/spotting in women using Norplant. |
| NCT00117273 ↗ | A Study to Evaluate Suppression of the Pituitary-Ovarian Axis With Three Different Oral Contraceptive Regimens | Completed | Duramed Research | Phase 3 | 2005-06-01 | This is a randomized, open-label study to evaluate pituitary ovarian suppression in healthy, reproductive-aged women using three different regimens of oral contraceptives (OCs). Two extended regimen OCs, Seasonale (levonorgestrel/ethinyl estradiol 0.15/0.03 mg for 84 days followed by 7 days of placebo), and Seasonique (levonorgestrel/ethinyl estradiol 0.15/0.03 mg for 84 days followed by 7 days of ethinyl estradiol 0.01 mg), and a 28-day regimen OC, Portia (levonorgestrel/ethinyl estradiol 0.15/0.03 mg for 21 days followed by 7 days of placebo). |
| NCT00128934 ↗ | Study Evaluating Combination of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) in Premenstrual Dysphoric Disorder | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 3 | 2005-08-01 | The purpose of this study is to determine whether levonorgestrel (LNG)/ethinyl estradiol (EE) is effective in treating the symptoms of severe premenstrual syndrome (PMS). |
| NCT00131885 ↗ | Effects of St. John's Wort on the Oral Contraceptive Hormone Levonorgestrel | Completed | National Center for Complementary and Integrative Health (NCCIH) | Phase 4 | 2005-08-01 | This study will determine the effects of St. John's wort, a common herbal remedy, on metabolism of the female contraceptive hormone levonorgestrel. |
| NCT00131885 ↗ | Effects of St. John's Wort on the Oral Contraceptive Hormone Levonorgestrel | Completed | University of Utah | Phase 4 | 2005-08-01 | This study will determine the effects of St. John's wort, a common herbal remedy, on metabolism of the female contraceptive hormone levonorgestrel. |
| NCT00161681 ↗ | Study Evaluating Levonorgestrel/Ethinyl Estradiol (LNG/EE) in PMS | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 3 | 2005-07-01 | The purpose of this study is to determine whether LNG/EE is effective in the treatment of menstrual cycle related symptoms. |
| NCT00185224 ↗ | Metabolism Study to Investigate the Impact of a Sequential Oral Contraceptive | Completed | Bayer | Phase 2 | 2005-03-01 | The purpose of this study is to confirm the safety of SH T00658ID with regard to plasma lipids, hemostatic variables, and carbohydrate metabolism. In addition, the pharmacokinetic parameter following the long term administration of SH T00658ID will be assessed. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for LEVONORGESTREL
Condition Name
Clinical Trial Locations for LEVONORGESTREL
Trials by Country
Clinical Trial Progress for LEVONORGESTREL
Clinical Trial Phase
Clinical Trial Sponsors for LEVONORGESTREL
Sponsor Name
